Harmony Biosciences Inc.

NASDAQ: HRMY · Real-Time Price · USD
31.60
-0.46 (-1.43%)
At close: Jun 25, 2025, 3:59 PM
32.38
2.47%
After-hours: Jun 25, 2025, 06:10 PM EDT
-1.43%
Bid 31.06
Market Cap 1.81B
Revenue (ttm) 744.85M
Net Income (ttm) 152.72M
EPS (ttm) 2.62
PE Ratio (ttm) 12.06
Forward PE 8
Analyst Buy
Ask 33.69
Volume 303,559
Avg. Volume (20D) 684,309
Open 32.23
Previous Close 32.06
Day's Range 31.25 - 32.23
52-Week Range 26.47 - 41.61
Beta 0.87

About HRMY

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol HRMY
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for HRMY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Harmony Biosciences Inc. is scheduled to release its earnings on Aug 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-9.64%
Harmony Biosciences shares are trading lower after... Unlock content with Pro Subscription
7 months ago
-18.53%
Harmony Biosciences shares are trading lower after the company announced a public offering of up to 8 million shares of common stock by selling shareholders Marshman Fund Trust II and Valor IV Pharma Holdings.